Hypopharyngeal carcinoma
MONDO:0005216Carcinoma, predominantly squamous cell, arising from the epithelial cells of the hypopharynx.
Also known as: cancer of hypopharynx, cancer of the hypopharynx, hypopharyngeal cancer, hypopharyngeal throat cancer, carcinoma of hypopharynx, carcinoma of the hypopharynx, hypopharyngeal carcinoma, hypopharynx carcinoma
3041 clinical trials for this condition and its sub-types, 36 tagged with Hypopharyngeal carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hypopharyngeal carcinoma
-
Hypopharynx squamous cell carcinoma 65 trials
-
Carcinoma in situ of hypopharynx 2 trials
1 sub-type
- Carcinoma in situ of epiglottis 0 trials
-
Epiglottis cancer 0 trials
1 sub-type
- Carcinoma in situ of epiglottis 0 trials
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
Can an immunotherapy combo shrink throat tumors before surgery?
Disease control Not yet recruitingThis phase 2 trial is testing whether giving the immunotherapy drug penpulimab together with chemotherapy before surgery can help people with locally advanced hypopharyngeal carcinoma, a type of head and neck cancer. The study will include about 15 adults aged 18 to 80 with resec…
Phase 2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC